Amrubicin CAS:110267-81-7, a potent anthracycline, effectively treats various cancers. This synthetic drug exhibits strong antitumor activity. It targets topoisomerase II, disrupting DNA replication. Amrubicin demonstrates fewer cardiotoxic effects compared to doxorubicin. The drug metabolizes into amrubicinol, increasing its efficacy. Administered intravenously, amrubicin is used for small cell lung cancer and relapsed aggressive non-Hodgkin lymphomas. Research on other malignancies continues.
Payloads and Linker modified Payloads
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.
日本语
한국어
Français
Deutsch
España
Türkiye